Abstract
Objective
To evaluate the diagnostic performance of a point-of-care (POC) test (SNAP 4Dx Plus; Idexx Laboratories Inc) versus a proprietary silicon surface multiplex immunoassay (SSMIA) test (Accuplex; Antech Diagnostics Inc) with indirect fluorescent antibody as the reference method (REFERENCE) for detecting antibodies against Anaplasma spp and Ehrlichia spp in dogs and to compare SSMIA test results with period prevalences reported by the Companion Animal Parasite Council (CAPC).
Methods
Anonymized retention-released serum samples from dogs in the US submitted to a commercial laboratory between July 1, 2023, and September 30, 2024, were classified as true positive or true negative for each antibody via REFERENCE. Performance metrics (sensitivity, specificity, and Cohen κ) were calculated (REFERENCE as the standard) for SSMIA versus POC. Additional separate serum samples from dogs in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania underwent SSMIA testing alone in July 2024, and results were compared with respective period prevalence data reported by the CAPC.
Results
Test methods did not differ significantly for detection of antibodies against Anaplasma spp (n = 310 samples). Silicon surface multiplex immunoassay was significantly more sensitive than POC for Ehrlichia spp antibody detection (n = 309 samples). Another 2,031 samples underwent SSMIA testing alone, and positivity rates were generally higher for SSMIA detection as compared to CAPC reporting.
Conclusions
These findings support SSMIA as a robust option for routine tick-borne pathogen exposure screening in dogs.
Clinical Relevance
Our work provides veterinarians with field and comparative performance data on 2 commercially available tests, informing evidence-based contextualized diagnostic options.
Keywords: Anaplasma spp; Ehrlichia spp; proprietary silicon surface multiplex immunoassay; Accuplex; point-of-care test
Introduction
With the continued global expansion and growing abundance of tick vectors and their transmitted pathogens, effective and comprehensive surveillance for endemic, emerging, and evolving pathogens is essential. Tick-borne disease pathogens can have both veterinary and human health importance. Examples of these pathogens in North America include the intracellular, gram-negative bacteria Anaplasma spp (Anaplasma phagocytophilum and Anaplasma platys) and Ehrlichia spp (Ehrlichia canis, Ehrlichia chaffeensis, and Ehrlichia ewingii). In dogs, serology-based (antibody) screening remains a reliable and recommended method for identifying exposure to tick-borne pathogens of veterinary and One Health significance.1–3
Veterinary teams routinely perform annual surveillance for Borrelia burgdorferi (Lyme borreliosis), Anaplasma spp, and Ehrlichia spp antibodies, typically in conjunction with heartworm (Dirofilaria immitis) antigen testing, as advised by expert- and evidence-based veterinary groups, like the Companion Animal Parasite Council (CAPC).1–4 Similar test methodologies (ie, immune migration and ELISA) for these tick-borne pathogens are commonly utilized by veterinary clinics, with various test options currently available at the point of care (POC) and reference laboratories.5–9 The most used commercially available serologic tests for tick-borne pathogen exposure in North America include a proprietary silicon surface multiplex immunoassay (SSMIA) (Accuplex; Antech Diagnostics Inc) and the POC tests SNAP 4Dx Plus (Idexx Laboratories Inc) and VetScan FLEX4 Rapid Test (Zoetis Services LLC).5–9
Testing methodologies for tick-borne disease pathogens differ in myriad aspects, such as which pathogens (and pathogen species and subspecies) are offered on a specific platform and what type and number of antibodies are detected (ie, single or multiple). With the emergence of different species and subspecies of Anaplasma and Ehrlichia in the US and Canada in recent years and the number of positive tests increasing rapidly in novel regions, many commercial test platforms have been modified in the past decade (eg, addition of A platys, E ewingii, and E chaffeensis to existing tests).5–9
Silicon surface multiplex immunoassay is utilized by veterinarians to detect C6 antibodies to B burgdorferi and screen for antibodies to 2 Anaplasma spp (A phagocytophilum and, A platys) and 3 Ehrlichia spp (E chaffeensis, E ewingii, and E canis), as well as antigens for D immitis (heartworm). This test platform, which consists of a proprietary SSMIA, has undergone several significant modifications, expansions, and enhancements in recent years to meet veterinary and One Health needs. Consequently, there is a need for performance and field validations of the currently offered platform to provide veterinarians with peer-reviewed evidence for clinical decision-making and accessible options for testing. Additionally, there is increasing recognition that contextualized diagnostics that allow for incorporation of spectrum of care in day-to-day practice are required to assist veterinarians in meeting pet owners where they are. This rising need requires a foundation of evidence and data on existing screening test options, optimally in the form of a current comparative evaluation of the 2 most used Anaplasma spp and Ehrlichia spp testing methodologies (ie, the SSMIA [Accuplex] and POC [SNAP 4Dx Plus]).
The primary objective of our study was to perform a comparative evaluation using remnant canine clinical samples and estimate diagnostic-test performance metrics for Anaplasma spp and Ehrlichia spp. These performance metrics included sensitivity, specificity, and the Cohen κ (as compared to the indirect fluorescent antibody [IFA] reference method [REFERENCE]), along with direct test-versus-test (SSMIA vs POC) comparisons. Point-of-care testing was used, as no validation publications for Lab 4Dx Plus were available. A secondary objective was to perform a field validation of the updated SSMIA screening platform for Anaplasma spp and Ehrlichia spp peptides and compare these test results to public period prevalence data obtained from the CAPC website for the same time frame and states.1
Leia o estudo completo:



